جست‌وجوی استاد و پژوهشگر

Janusz Bujnickiمشاهده پروفایل

استاد

• Structural Biology
• Bioinformatics
• Computational Biology
• +۴ مورد دیگر

Janusz Bujnicki is a Professor and head of the Laboratory of Bioinformatics and Protein Engineering at the International Institute of Molecular and Cell Biology in Warsaw (IIMCB), Poland. He holds concurrent roles in science policy advisory bodies, including the European Commission's Group of Chief Scientific Advisors (2015-2020, then expert) and the Polish Academy of Sciences’ advisory panel (2024-). He is also a founding member of the Association of ERC Grantees (AERG) and serves on the Scientific Advisory Board of Life Science Center at Vilnius University. Academia Europaea Member (2018-) EMBO Member (2018-) Leadership Academy for Poland (2018) His research spans structural biology, RNA modification, computational biology, and molecular evolution. He has pioneered computational methods like ModeRNA, SimRNA, and ClaRNA for RNA structure prediction and analysis, and developed databases like MODOMICS for RNA modification pathways. His work has applications in understanding RNA function and drug design targeting RNA-processing enzymes. The 15 most recent publications focus on RNA structural modeling (e.g., ModeRNA, ClaRNA, SupeRNAlign), RNA-ligand interactions (LigandRNA), and RNA modification biology (MODOMICS database). These works bridge computational methods with experimental validation in RNA enzymology and structure-function relationships. Scientific Awards: ERC Starting Grant (2010), EMBO Member (2018), Crystal Brussels Sprout (2016), Prime Minister’s Award (2014), Knight’s Cross of Polonia Restituta (2014) Grants & Leadership: Founded RNA bioinformatics infrastructure at IIMCB, led EU science policy advisory groups, and organized international research competitions (RNA Puzzles)

• Developmental Neurobiology
• RNA Modification
• Post-transcriptional Regulation
• +۴ مورد دیگر

Dr. Sheng-Jian Ji is a Tenured Associate Professor at the School of Life Sciences, Department of Neuroscience at Southern University of Science and Technology (SUSTech) in Shenzhen, China. He also serves as the Academic Vice President of Shude Academy and was previously the first Deputy Director of Research and Graduate Affairs in the Department of Biology at SUSTech (2016-2018). As a leading neuroscientist specializing in RNA modification and neural development, Dr. Ji has established an internationally recognized research program. Dr. Ji's educational background includes: 2003-2007: Postdoctoral Fellow, Johns Hopkins University School of Medicine, Neurobiology 1998-2003: PhD in Biochemistry and Molecular Biology, Peking University School of Life Sciences 1994-1998: Bachelor's Degree in Biochemistry, Yantai University Department of Biochemistry Dr. Ji's research primarily focuses on developmental neurobiology, with particular emphasis on post-transcriptional regulation mechanisms including RNA modification and local translation of mRNA in axons. His laboratory is recognized as one of the leading international groups studying how mRNA modification (particularly m6A and m5C) regulates neural development and function. Through innovative approaches combining molecular biology, cell biology, and microfluidic technologies, his team has revealed important insights into axon growth, dendrite maintenance, cortical neurogenesis, and retinal development. His publication record shows a clear trajectory from fundamental mechanisms of RNA modification to applications in understanding neurological disorders and aging. Recent work has expanded into aging-related neural decline, cognitive functions, and potential therapeutic targets for neurological conditions. Dr. Ji has received numerous prestigious awards: 2020, 2016: SUSTech Excellent College Mentor 2020: SUSTech Biology Department Outstanding Service Award 2019: Guangdong Province Talent Youyue Card A 2017: Guangdong Provincial Professor of Neurobiology 2013: Jiangsu Distinguished Professor (Nanjing University) 2011: National Natural Science Award Second Prize (third contributor) As an educator, Dr. Ji teaches undergraduate Neurobiology and graduate Cellular and Molecular Neurobiology courses. He actively mentors students, with recent master's graduates including Yuan Jiaxin and Zhang Pingrui. His laboratory recruits postdoctoral fellows (with salaries of 335,000+ RMB annually), research assistants, and graduate students, providing comprehensive training in molecular techniques, neuronal cell culture, microfluidics, and omics approaches. Dr. Ji leads a vibrant research team that collaborates both within SUSTech and internationally. His work continues to advance understanding of RNA modification in neural development, function, and aging, with recent progress highlighted in June 2025.

Zhishan Wangمشاهده پروفایل

استاد پژوهشی

• Environmental Carcinogenesis
• Cancer Biology
• Cancer Therapy
• +۴ مورد دیگر

Zhishan Wang, MD, PhD is a Research Professor in the Department of Pathology at Stony Brook University's Renaissance School of Medicine . His work focuses on environmental carcinogenesis , particularly mechanisms of cancer biology and cancer therapy , with a specialization in metal-induced carcinogenicity. Research Interests: Environmental Carcinogenesis Epigenetic and Epitranscriptomic Mechanisms Tumor Microenvironment Remodeling Metal Toxicity Pathobiology Non-Coding RNA Regulatory Networks Scientific Contributions: Analysis of 15 recent publications reveals expertise in: Metal-Induced Oncogenic Pathways (e.g., NF-κB activation, Hedgehog signaling) RNA Modification Dynamics (m6A, lncRNA-splicing interactions) Stem Cell Plasticity in Carcinogenesis Multi-Carcinogen Synergy Mechanisms Epigenetic-Genotoxic Interplay Transcriptomic Reprogramming by Toxicants

Jianjun Chenمشاهده پروفایل

استاد

• RNA Epigenetics
• DNA Epigenetics
• Cancer Biology
• +۷ مورد دیگر

Jianjun Chen, Ph.D. serves as Professor and Chair of the Department of Systems Biology and Director of the Center for RNA Biology and Therapeutics at City of Hope's Beckman Research Institute. Appointed Chair in August 2020, he previously served as Professor and Vice Chair from 2017-2020. He also holds the Simms/Mann Family Foundation Chair in Systems Biology since 2018. Dr. Chen's research focuses on RNA and DNA epigenetic mechanisms in cancer development and therapy resistance. His laboratory has made seminal contributions to understanding RNA modifications including N⁶-methyladenosine (m⁶A), 5-methylcytosine (m⁵C), and 7-methylguanosine (m⁷G), and their roles in cancer initiation, progression, drug resistance, and immune evasion. The lab also studies DNA epigenetic regulation through TET proteins and develops novel therapeutic strategies targeting epigenetic regulators. His recent publications reveal trends in RNA epigenetics, cancer metabolism, immune evasion mechanisms, and therapeutic targeting of epigenetic regulators. His work spans multiple cancer types including leukemia, lymphoma, and solid tumors, with emphasis on translating basic discoveries into clinical applications. Research Scholar of the American Cancer Society (2011) Scholar of The Leukemia & Lymphoma Society (2017) Researcher of the Year, The Pamela B. Katten Memorial Leukemia Research Foundation Award (2014) The Leukemia & Lymphoma Society Scholar CDP Achievement Award (2022) Fellow of the American Association for the Advancement of Science (AAAS) (2023) Dr. Chen's research program is supported by multiple R01 grants from the National Cancer Institute. His laboratory actively mentors researchers and has developed several small-molecule inhibitors with strong therapeutic potential in preclinical models. The Chen Laboratory is dedicated to translating fundamental discoveries in RNA and DNA epigenetics into effective clinical therapies for cancer patients. The laboratory operates within City of Hope's comprehensive cancer center, collaborating with clinical teams to bridge basic research and patient care. Current projects focus on developing prognostic systems for cancer risk stratification and creating targeted therapeutic strategies that inhibit aberrant epigenetic regulators such as FTO, IGF2BP2, YTHDF2, METTL16, and TET1.

Eduardo Eyrasمشاهده پروفایل

استاد

• RNA Biology
• Cancer Research
• Long-read Sequencing Technologies
• +۴ مورد دیگر

Eduardo Eyras is a Professor at the Australian National University (ANU) and EMBL Australia Group Leader, leading research in computational RNA biology and cancer genomics. He directs the Centre for Computational Biomedical Sciences and is part of the Shine-Dalgarno Centre for RNA Innovation. His work focuses on transcriptome and epitranscriptome analysis using long-read sequencing, machine learning, and computational methods to study cancer mechanisms. Eyras holds a PhD in Mathematics from the University of Groningen (1999) and previously led research at the Sanger Institute and Pompeu Fabra University. Affiliations: Director, Centre for Computational Biomedical Sciences Researcher, Shine-Dalgarno Centre for RNA Innovation Member, Division of Genome Sciences and Cancer Leader, The Eyras Group - Computational RNA Biology Research Interests: Development of algorithms for long-read sequencing Machine learning applications in RNA biology Epitranscriptomic modifications and cancer Therapeutic mRNA platform steering Key Projects: Novel algorithms for transcriptome variation analysis Predictive models of RNA modifications in disease Ribosomal DNA variation analysis Advisees & Grants: Supervises PhD students (e.g., Favour Oyelami, Stefan Prodic) and leads ARC-funded projects on mRNA diagnostics and epitranscriptomic therapies. Collaborates with global teams on forensic genomics, cancer drug resistance, and AI-driven translational research. Labs/Teams: Leads the Eyras Group, collaborating with the Hannan Group (Cancer Therapeutics) and Shirokikh Group (Protein Biosynthesis).

Ian J. Mohrمشاهده پروفایل

استاد

• Post-transcriptional gene regulation
• Virology
• RNA Biology
• +۳ مورد دیگر

Ian J. Mohr, PhD is a Professor in the Department of Microbiology at NYU Grossman School of Medicine. His research focuses on post-transcriptional control of gene expression during virus infection, intersecting virology, RNA biology, and genome integrity. Education PhD in Molecular Biology from Stony Brook University Postdoctoral Training at University of California, Berkeley (Molecular and Cell Biology) Research Interests Mohr's lab investigates how physiological stress and viral infections dysregulate translational control, RNA metabolism, and gene expression. Key areas include: RNA modifications (e.g., m6A) in viral replication Translational control during viral infection Host antiviral responses targeting mRNA decay Stress signaling in virus-infected cells Herpesvirus latency and reactivation Recent Trends in Research Mohr's recent publications emphasize RNA modifications and translational regulation in herpesvirus infections, particularly HCMV and HSV-1. His work explores: Epitranscriptomic mechanisms in viral RNA accumulation Integration of stress response pathways with viral replication Computational approaches for RNA modification detection Role of nuclear body assembly in viral pathogenesis Laboratory Mohr leads the Mohr Lab at NYU Langone's virology research group. His lab collaborates extensively with other virology and RNA biology teams, particularly with Associate Professor Angus C. Wilson's lab, with which he has co-mentored trainees and secured joint grants.

Timothy Bredyمشاهده پروفایل

دانشیار

• Epigenetics
• Fear-Related Memory
• RNA Biology
• +۶ مورد دیگر

Associate Professor Timothy Bredy is a leading figure in cognitive neuroepigenetics at the Queensland Brain Institute (QBI) , focusing on how epigenetic modifications and RNA dynamics regulate fear-related memory and psychiatric disorders like PTSD. His research explores the interplay between environmental experiences and genomic activity, particularly through non-coding RNA and DNA methylation. University: University of Queensland School: Faculty of Health, Medicine and Behavioural Sciences Role: Professorial Research Fellow and Group Leader Research Interests span epigenetic mechanisms in memory formation, RNA modifications in synaptic plasticity, and therapeutic applications for anxiety disorders. He pioneered discoveries linking dynamic DNA structures (e.g., G-quadruplexes) and RNA methylation to memory stability. Recent Work includes studies on RNA-based therapeutics, stress-induced epigenetic inheritance, and synaptic long noncoding RNA activity. His scientific awards encompass NHMRC and ARC grants for neuroepigenetics research. Key Collaborators: Paul Marshall, Esmi Zajaczkowski Labs: Bredy Laboratory at QBI

Laura Leightonمشاهده پروفایل

پژوهشگر ارشد

• RNA Biology
• mRNA Therapeutics
• Gene Therapy
• +۳ مورد دیگر

Dr. Laura Leighton is a Postdoctoral Research Fellow in the mRNA Sciences group at the Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland. Her research focuses on RNA biology, particularly the functional characterization of RNA molecules and their roles in cancer therapy and neurological processes. She leads the development of mRNA-based therapeutics for liver cancer, leveraging lipid nanoparticle (LNP) delivery systems to target intracellular cancer proteins. Dr. Leighton holds a PhD from the Queensland Brain Institute (2021), where her work, supported by the Westpac Future Leaders Scholarship, explored small noncoding RNAs in fear-related learning and memory. She completed her postdoctoral training under Dr. Seth Cheetham at AIBN in 2023. Her educational background includes a Bachelor of Science and Bachelor of Science (Honours) from The University of Queensland. Her research interests integrate molecular biology, neuroscience, and translational medicine, with a focus on RNA modifications (e.g., m6A), long noncoding RNAs, and the epigenetic regulation of memory processes. Key themes in her work include fear extinction mechanisms, synaptic plasticity, and the application of mRNA therapeutics in cancer treatment. Dr. Leighton’s articles consistently explore RNA-driven mechanisms in memory and disease. Recent work highlights the role of DNA G-quadruplex structures in memory regulation, the interplay between stress hormones and sperm RNA dysregulation, and the synthesis of novel long noncoding RNAs (e.g., ADRAM) that drive fear extinction. Her findings bridge basic neuroscience and clinical applications, emphasizing RNA’s dynamic role in health and disease. Awards: Westpac Future Leaders Scholarship (2017) Grants: TdC Mid Career Grant (Targeting liver cancer with mRNA therapies), Prader Willi Syndrome Research Grant (2022–2024) She is actively involved in supervising research students and contributes to the development of advanced drug delivery systems targeting liver cancers. Her lab is part of AIBN’s mRNA Sciences team, collaborating on projects that translate RNA-based discoveries into clinical solutions.

Alexey Petrovمشاهده پروفایل

دانشیار

• Translational Biology
• Ribosome Function
• Protein Synthesis
• +۷ مورد دیگر

Alexey Petrov is an Associate Professor in the Department of Biological Sciences at Auburn University, affiliated with the College of Sciences and Mathematics. His research focuses on the molecular mechanisms of protein synthesis, particularly ribosome dynamics and translational regulation. His research interests lie at the intersection of biochemistry, biophysics, and molecular biology. He investigates how ribosomes achieve high-speed and high-fidelity protein synthesis, how mRNA structure and modifications regulate translation, and how viral elements hijack the translational machinery. His lab employs cutting-edge single-molecule fluorescence techniques and biochemical assays to dissect these processes in real time. The recent publications highlight a strong focus on ribosome translocation, initiation, elongation fidelity, and the impact of mRNA modifications such as 2′-O-methylation and m6A on translation dynamics. His work frequently involves the study of viral internal ribosome entry sites (IRES), providing insights into alternative translation mechanisms. The research is characterized by a deep mechanistic and kinetic understanding of translation, often revealing multiple parallel pathways and dynamic conformational changes. Alexey Petrov received his B.S. from Moscow State University, Russia, followed by a Ph.D. from the University of Maryland, College Park, under Dr. Jonathan Dinman. He completed his postdoctoral training with Dr. Joseph D. Puglisi at Stanford University, where he pioneered single-molecule studies of translation. Postdoctoral fellow with Dr. Joseph D. Puglisi, Stanford University Ph.D. with Dr. Jonathan Dinman, University of Maryland, College Park B.S., Moscow State University, Russia He leads an active research group within Auburn University's Biophysics Cluster, established in 2017. His lab is dedicated to advancing the single-molecule toolbox by developing new instrumentation and data analysis pipelines to make these powerful techniques more accessible. While specific grants are not listed, his publication record in top journals suggests a well-funded and productive research program. He mentors students and postdoctoral researchers in biochemical and biophysical methods, contributing to the training of the next generation of scientists.

Benjamin Wolozinمشاهده پروفایل

استاد

• Neurodegenerative Diseases
• Alzheimer's Disease
• Parkinson's Disease
• +۷ مورد دیگر

Benjamin Wolozin is a Professor at the Boston University Chobanian & Avedisian School of Medicine in the Department of Pharmacology , with an adjunct position in Neurology. He specializes in neurodegenerative diseases, particularly Alzheimer's , Parkinson's , and ALS . MD/PhD, Albert Einstein College of Medicine Past Associate Professor at Loyola University Medical Center (1996-2004) Current affiliations: Alzheimer's Disease Center, Boston University Graduate Program for Neuroscience His research investigates RNA binding proteins (RBPs) , stress granules , and liquid-liquid phase separation in neurodegenerative disease. Key projects include the role of TIA1 and HNRNPA2B1 in tauopathy, m6A RNA methylation in Alzheimer's pathology, and development of 3D iPS-neuron/astrocyte assembloids to model dementia. His lab has identified disease-linked circRNA changes and explores nanobodies targeting stress granule components. Recent awards include the Donald B. Lindsley Prize (Society for Neuroscience) and A. E. Bennett Award . He serves on NIH CDIN study sections and editorial boards for Journal of Biological Chemistry and Neurodegenerative Diseases . Grants include multiple NIH R01 and U01 awards for AD/tauopathy research.

• RNA Biology
• Cancer Biology
• Translational Regulation
• +۳ مورد دیگر

Stephan Vagner serves as Director of Research Unit Genome Integrity, RNA and Cancer (UMR3348) and Team Leader of RNA Biology, Signalling and Cancer (U1278) at Institut Curie in Orsay, while holding a professorship at Ecole Polytechnique since 2018. His leadership roles include Site Coordinator of the Research Center and Director of CNRS UMR3348/INSERM U1278 since 2020. Dr. Vagner's research focuses on RNA regulations and RNA-binding proteins in cancer biology, with three primary axes: (1) DNA damage response mechanisms including intronic polyadenylation, (2) Tumor-intrinsic resistance to targeted therapies through mRNA translation reprogramming, and (3) Tumor cell-environment crosstalk in melanoma and leukemia. His work employs biochemical analyses, genome-wide RNA studies, and in vivo tumor models across cutaneous melanoma, breast cancer, and acute T lymphoblastic leukemia. Analysis of his publication history reveals sustained expertise in translational regulation during therapy resistance, with recent emphasis on unconventional RNA-binding activities of metabolic enzymes and genotoxic stress responses. His collaborative network spans Institut Curie, CNRS, Inserm, and Ecole Polytechnique. As Team Leader, he mentors researchers across multiple projects investigating RNA-protein interactions in cancer progression. His laboratory utilizes advanced techniques including RNA-seq, 3'seq, polysome profiling, and iCLIP for RNA-protein interaction studies. The RNA Biology, Signalling and Cancer team operates within the Genome Integrity, RNA and Cancer unit, focusing on co-/post-transcriptional gene regulation in therapeutic contexts through biochemical, genomic, and phenotypic analyses.

Michiel Vermeulenمشاهده پروفایل

استاد

• Systems Biology
• Proteomics
• Cellular Differentiation
• +۸ مورد دیگر

Michiel Vermeulen is a Full Professor in Proteomics and Chromatin Biology at the Department of Molecular Biology, Radboud University Nijmegen, Netherlands. He previously held positions as Associate and Assistant Professor at University Medical Center Utrecht (2009-2014) and completed postdoctoral work at Max Planck Institute for Biochemistry (2005-2009) and a PhD at Radboud University (2000-2005). His research focuses on integrative omics approaches to study gene expression regulation in development and disease, particularly through chromatin interactions and post-translational modifications. Education: PhD in Molecular Biology, Radboud University Nijmegen (2000-2005) Postdoc in Proteomics & Signal Transduction, Max Planck Institute Munich (2005-2009) His work pioneers quantitative mass spectrometry technologies to analyze chromatin-associated proteins, including m6A RNA modifications and ubiquitin signaling. He has published 97 papers and received multiple accolades, including ERC Starting and Consolidator Grants, a VIDI award, and membership in the Oncode Institute. His lab leads collaborative studies on chromatin readers, DNA damage response, and transcriptional regulation. Scientific Awards: ERC Consolidator Grant (2017) ERC Starting Grant (2012) Vernieuwingsimpuls VIDI award (2009) Max Planck Institute Junior Research Award (2008) Van Nieuwenhoven Award for Best Master Student (2000) Oncode Institute Founding Member (2017) Vermeulen's lab collaborates internationally and mentors 6 PhD students, 6 postdocs, and technicians, emphasizing high-impact interdisciplinary research in chromatin biology and systems-level gene regulation.

• Functional genomics
• tRNA biology
• Microbiome
• +۴ مورد دیگر

Professor Tao Pan is a leading researcher in RNA biology at the University of Chicago's Department of Biochemistry and Molecular Biology. His laboratory pioneers methodologies for studying tRNA dynamics, epitranscriptomics, and microbiome-host interactions through innovative sequencing technologies. His research spans three interconnected domains: tRNA biology : Developing high-throughput sequencing to measure tRNA abundance, charging, and modifications, revealing roles in translational control and extratranslational functions Microbiome characterization : Creating tRNA-seq as an RNA-based alternative to 16S/shotgun metagenomics to capture dynamic microbiome activity Epitranscriptomics : Investigating mRNA modifications like m6A in gene regulation, discovering the 'm6A switch' mechanism affecting RNA structure and protein binding His publication trends demonstrate consistent innovation in RNA modification mapping techniques, with recent work focusing on nanopore sequencing applications, microbiome-induced epitranscriptomic reprogramming, and therapeutic mRNA engineering. Key recurring themes include tRNA modification dynamics, host-microbiome crosstalk, and RNA modification detection methodologies. Scientific recognition includes: NIH Director's Pioneer Award (2011-2016) NIH EUREKA Award (2009-2013) AAAS Fellow (2015) Multiple early-career cancer research awards His laboratory maintains substantial NIH funding through multiple R01 grants (current awards totaling >$5M annually), focusing on tRNA sequencing applications in cancer (R33CA272357), microbiome-host interactions (R21AI169280), and snoRNA functions (R01HG012780). The Pan Lab has established tRNA-seq as a novel microbiome characterization platform and pioneered discoveries in m6A-mediated RNA structural switching. Research infrastructure includes development of specialized sequencing technologies for simultaneous tRNA modification and fragmentation analysis, with recent expansion into nanopore-based direct RNA modification detection. Current work explores therapeutic applications of tRNA modification knowledge in cancer and infectious disease contexts.

• Genomics
• Epigenetics
• Systems Biology
• +۷ مورد دیگر

Gary Hon is an Assistant Professor at the University of Texas Southwestern Medical Center (UTSW), jointly affiliated with the Cecil H. and Ida Green Center for Reproductive Biology Sciences and the Lyda Hill Department of Bioinformatics. His research lies at the intersection of genomics, epigenetics, and systems biology, with a focus on decoding the regulatory complexity of the human genome. His research interests include: Understanding the molecular basis of cell state for applications in regenerative medicine Elucidating how non-coding genetic variants contribute to development and disease Developing integrative techniques combining gene regulation, epigenetics, genome engineering, and single-cell genomics Advancing bioinformatics tools for analyzing chromatin and transcriptional regulation The trends across his recent publications reveal a strong emphasis on enhancer biology, epigenetic modifications (especially 5mC and 5hmC), single-cell functional genomics, and the development of novel molecular tools such as in situ chromatin capture and combinatorial perturbation assays. His work frequently leverages CRISPR-based technologies and high-throughput sequencing to dissect gene regulatory networks. Dr. Hon has received significant recognition for his innovative research, including: CPRIT Scholar NIH Director’s New Innovator Award Dr. Hon leads the Hon Lab, which actively develops and applies systems-level approaches to study genome regulation. His collaborative research involves advising graduate students and postdoctoral fellows, many of whom appear as co-authors on his publications. While specific grant details are not listed, his prestigious awards suggest substantial federal and state funding support for his high-impact, interdisciplinary research program.

Alexandra Lusserمشاهده پروفایل

استاد

• Chromatin remodeling
• Chromatin assembly
• Epigenetics
• +۵ مورد دیگر

Professor Alexandra Lusser serves as Professor and Deputy Head in the Department of Molecular Biology at Innsbruck Medical University, where she leads the Chromatin and Epigenetics Laboratory. Her research focuses on understanding the molecular mechanisms of chromatin assembly, remodeling, and epigenetic regulation at both DNA and RNA levels. Professor Lusser completed her PhD at the University of Innsbruck in 1998, followed by postdoctoral training at the University of California, San Diego (2001-2004) in the laboratory of Professor JT Kadonaga. She joined Innsbruck Medical University as Assistant Professor in 2004, achieved her Habilitation for Molecular Biology in 2008, was promoted to Associate Professor, and became a full Professor in 2019. Her research program investigates how eukaryotic DNA is organized in chromatin and how this organization affects DNA metabolism processes including transcription, replication, repair, and recombination. A significant portion of her work examines ATP-dependent chromatin assembly and remodeling mechanisms, variant histone assembly, and epigenetic mechanisms at the mRNA level, particularly mRNA base modifications such as 5-methylcytosine and their roles in mRNA metabolism and translation. Her publications reveal a strong focus on developing and applying innovative biochemical and genomic techniques to study RNA modifications and chromatin dynamics. Professor Lusser's extensive publication record spanning from 1996 to the present demonstrates consistent contributions to the fields of chromatin biology and RNA epigenetics. Her recent work shows particular emphasis on developing novel sequencing methods for RNA modification analysis, exploring the functional consequences of RNA modifications, and investigating the relationship between chromatin remodeling factors and neurological functions. HOECHST Award (1998) APART 3-year postdoctoral fellowship from the Austrian Academy of Sciences (2001) START Prize from the Ministry of Science and Research (2005) Member of the Young Curia of the Austrian Academy of Sciences (2008-2016) Research Award from the State Capital Innsbruck (2009) As Deputy Head of the Department of Molecular Biology, Professor Lusser contributes to departmental leadership while maintaining an active research program. Her laboratory has developed several important methodologies including TUC-Seq for measuring mRNA transcription and degradation rates, bisulfite sequencing for detecting 5-methylcytosine in RNA, and other innovative approaches for studying RNA modifications. Her work bridges molecular biology, biochemistry, and genomics, with implications for understanding fundamental biological processes and potential applications in disease research.